189 related articles for article (PubMed ID: 37181039)
1. Vitamin D deficiency linked to abnormal bone and lipid metabolism predicts high-risk multiple myeloma with poorer prognosis.
Bao L; Wang YT; Lu MQ; Chu B; Shi L; Gao S; Fang LJ; Xiang QQ; Ding YH; Liu X; Zhao X; Wang MZ; Chen Y; Hu WK
Front Endocrinol (Lausanne); 2023; 14():1157969. PubMed ID: 37181039
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients.
Bao L; Wang Y; Lu M; Chu B; Shi L; Gao S; Fang L; Xiang Q
Cancer Med; 2020 Dec; 9(23):8962-8969. PubMed ID: 33145966
[TBL] [Abstract][Full Text] [Related]
3. [The roles of serum free light chain ratio in the diagnosis and prognosis of newly diagnosed multiple myeloma].
Wang PF; Xu Y; Yan S; Yao Y; Zheng HF; Ma L; Jin S; Xu Y; Gong FR; Zhou JZ; Chang HR; Fu CC
Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):377-82. PubMed ID: 27210871
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics of bone disease in multiple myeloma and clinical significance of monitoring bone metabolic markers].
Chu B; Lu MQ; Wu MQ; Shi L; Fu LN; Gao S; Fang LJ; Xiang QQ; Bao L
Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1424-9. PubMed ID: 27266350
[TBL] [Abstract][Full Text] [Related]
5. [Clinical Significance of Serum ADA Combined with GLB, CREA, β
Qian H; Yuan HL; Zhang T; Yang YW; Feng JF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):780-788. PubMed ID: 38926967
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of semi-quantitative parameters of
Wan B; Zhang S; Wang P; Deng P; Dai W
Ann Nucl Med; 2023 Mar; 37(3):155-165. PubMed ID: 36528697
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of clinical and prognostic characteristics of newly diagnosed multiple myeloma with myelofibrosis patients].
Zhang L; Li YL; Liu YM; Liu YB; Shang BJ; Cheng W; Dong XY; Zhu ZM
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):57-62. PubMed ID: 38178769
[No Abstract] [Full Text] [Related]
8. Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
Du J; Lu J; Gao W; Liu J; He H; Li L; Li R; Zhou L; Jiang H; Chen W; Fu W; Hou J
Ann Hematol; 2020 Aug; 99(8):1779-1791. PubMed ID: 32594218
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the clinical characteristics and prognosis of 36 cases of newly diagnosed multiple myeloma patients with bone marrow monoclonal plasma cell ratio of less than 10].
Zhao JT; Jiang XY; Yang C; Chen M; Lan XL; Du JH; Zhou DB; Zhuang JL
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):295-301. PubMed ID: 33979973
[No Abstract] [Full Text] [Related]
10. [Predictive Value of Pre-treatment Serum Uric Acid Level for Prognosis in Newly Diagnosed Patients with Multiple Myeloma].
Xu SQ; Zhao P; Wang ZH; Deng H; Zhang L; Wei J; Zou XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1216-1223. PubMed ID: 34362505
[TBL] [Abstract][Full Text] [Related]
11. Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma.
Ng AC; Kumar SK; Rajkumar SV; Drake MT
Am J Hematol; 2009 Jul; 84(7):397-400. PubMed ID: 19415724
[TBL] [Abstract][Full Text] [Related]
12. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.
D'Agostino M; Cairns DA; Lahuerta JJ; Wester R; Bertsch U; Waage A; Zamagni E; Mateos MV; Dall'Olio D; van de Donk NWCJ; Jackson G; Rocchi S; Salwender H; Bladé Creixenti J; van der Holt B; Castellani G; Bonello F; Capra A; Mai EK; Dürig J; Gay F; Zweegman S; Cavo M; Kaiser MF; Goldschmidt H; Hernández Rivas JM; Larocca A; Cook G; San-Miguel JF; Boccadoro M; Sonneveld P
J Clin Oncol; 2022 Oct; 40(29):3406-3418. PubMed ID: 35605179
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Significance of Vitamin D Deficiency in Korean Patients With Multiple Myeloma.
Kim S; Cho H; Kim M; Lee K; Kim S; Yoon DH
Clin Lymphoma Myeloma Leuk; 2024 Mar; 24(3):e112-e118. PubMed ID: 38177055
[TBL] [Abstract][Full Text] [Related]
14. A prognostication system based on clinical parameters and [
Li J; Zhang X; Qin C; Sun X; Xu X; Cao G; Gai Y; Sun C; Hu Y; Lan X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1665-1670. PubMed ID: 36576511
[TBL] [Abstract][Full Text] [Related]
15. Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels.
Eicher F; Mansouri Taleghani B; Schild C; Bacher U; Pabst T
Hematol Oncol; 2020 Oct; 38(4):523-530. PubMed ID: 32594534
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma.
Zhang L; Chen S; Huang M; Wang W; Liang Y; Wang Y
Ann Hematol; 2023 Jan; 102(1):125-132. PubMed ID: 36441260
[TBL] [Abstract][Full Text] [Related]
17. [Expression and Clinical Significance of NAMPT in Bone Marrow of Patients with Multiple Myeloma].
Wang YR; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1739-1744. PubMed ID: 38071054
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and outcomes of patients newly diagnosed with multiple myeloma with extramedullary disease].
Wang J; Zhang LN; Shi QL; Qu XY; Chen LJ; Li JY; Zhang R
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):822-828. PubMed ID: 33190439
[No Abstract] [Full Text] [Related]
19. [The impact of low T3 syndrome on the prognosis of patients with newly diagnosed multiple myeloma].
Zhang J; Zhang LN; Xia Y; Jin YY; Shen XX; Chen LJ
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):216-221. PubMed ID: 37356983
[No Abstract] [Full Text] [Related]
20. Myc rearrangement redefines the stratification of high-risk multiple myeloma.
Jin X; Li H; Zhang D; Liu S; Song Y; Zhang F; Li Z; Zhuang J
Cancer Med; 2024 Jun; 13(11):e7194. PubMed ID: 38845529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
